Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125978022 | 12597802 | 2 | F | 20150609 | 20160726 | 20160728 | PER | US-MYLANLABS-2015M1019930 | MYLAN | 0.00 | M | Y | 0.00000 | 20160728 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125978022 | 12597802 | 1 | PS | Atorvastatin Calcium Tablets | ATORVASTATIN CALCIUM | 1 | Oral | 10 MG, PM | 91226 | 10 | MG | TABLET | QD | ||||||
| 125978022 | 12597802 | 2 | SS | Levothyroxine Sodium Tablets, USP | LEVOTHYROXINE SODIUM | 1 | Oral | 25 ?G, AM | 0 | 25 | UG | TABLET | QD | ||||||
| 125978022 | 12597802 | 3 | C | MOTRIN | IBUPROFEN | 1 | UNK, PRN | 0 | |||||||||||
| 125978022 | 12597802 | 4 | C | ALEVE | NAPROXEN SODIUM | 1 | UNK, PRN | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125978022 | 12597802 | 1 | Blood cholesterol increased |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125978022 | 12597802 | Drug interaction | |
| 125978022 | 12597802 | Muscle spasms |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125978022 | 12597802 | 2 | 2014 | 0 |